Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition
Marco Colizzi, Mirella Ruggeri, Sagnik Bhattacharyya
Frontiers in Psychology (2020) Vol. 11
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test
Ila Marques Porto Linares, Antônio Waldo Zuardi, Luis C. Pereira, et al.
Brazilian Journal of Psychiatry (2018) Vol. 41, Iss. 1, pp. 9-14
Open Access | Times Cited: 203
Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses
Zeinab Breijyeh, Buthaina Jubeh, Sabino Aurelio Bufo, et al.
Toxins (2021) Vol. 13, Iss. 2, pp. 117-117
Open Access | Times Cited: 84
Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada
Daniel T. Myran, Rhiannon Roberts, Michael Pugliese, et al.
JAMA Network Open (2022) Vol. 5, Iss. 9, pp. e2231937-e2231937
Open Access | Times Cited: 43
Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review
Ahmed Hasbi, Bertha K. Madras, Susan R. George
Brain Sciences (2023) Vol. 13, Iss. 2, pp. 325-325
Open Access | Times Cited: 38
Changes in Cannabis-Attributable Hospitalizations Following Nonmedical Cannabis Legalization in Canada
Daniel T. Myran, Adrienne Gaudreault, Lauren Konikoff, et al.
JAMA Network Open (2023) Vol. 6, Iss. 10, pp. e2336113-e2336113
Open Access | Times Cited: 25
Cannabis for Chronic Pain: Mechanistic Insights and Therapeutic Challenges
Carla Matos, Ana Teresa Pereira, Maria João Dias, et al.
Stresses (2025) Vol. 5, Iss. 1, pp. 7-7
Open Access | Times Cited: 1
The Impact of Cannabidiol on Human Brain Function: A Systematic Review
Albert Batalla, Julian Bos, Amber Postma, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 50
TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids
Kathleen Louis-Gray, Srinivasan Tupal, Louis S. Premkumar
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10016-10016
Open Access | Times Cited: 32
Recommendations for Reducing the Risk of Cannabis Use-Related Adverse Psychosis Outcomes: A Public Mental Health-Oriented Evidence Review
Benedikt Fischer, Wayne Hall, Thiago Marques Fidalgo, et al.
Journal of Dual Diagnosis (2023) Vol. 19, Iss. 2-3, pp. 71-96
Open Access | Times Cited: 14
Lipid-based formulations to increase cannabidiol bioavailability: In vitro digestion tests, pre-clinical assessment and clinical trial
Manuel A.A. De Prá, Renata Vardanega, Carla Giane Loss
International Journal of Pharmaceutics (2021) Vol. 609, pp. 121159-121159
Closed Access | Times Cited: 30
Natural and Synthetic Cannabinoids: Pharmacology, Uses, Adverse Drug Events, and Drug Interactions
Joshua D. Brown, Kevin J. Rivera Rivera, Leilanie Y. Crespo Hernandez, et al.
The Journal of Clinical Pharmacology (2021) Vol. 61, Iss. S2
Open Access | Times Cited: 29
Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing
Elizabeth A. Cairns, Melissa J. Benson, Miguel A. Bedoya‐Pérez, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Deciphering the mechanisms of reciprocal regulation or interdependence at the cannabinoid CB1 receptors and cyclooxygenase-2 level: Effects on mood, cognitive implications, and synaptic signaling
Katarzyna Stachowicz
Neuroscience & Biobehavioral Reviews (2023) Vol. 155, pp. 105439-105439
Closed Access | Times Cited: 9
The Yin and Yang of Cannabis: A Systematic Review of Human Neuroimaging Evidence of the Differential Effects of Δ9-Tetrahydrocannabinol and Cannabidiol
Brandon Gunasekera, Cathy Davies, Rocío Martín‐Santos, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2020) Vol. 6, Iss. 6, pp. 636-645
Closed Access | Times Cited: 27
Long-Term Consequences of Adolescent Exposure to THC-Rich/CBD-Poor and CBD-Rich/THC-Poor Combinations: A Comparison with Pure THC Treatment in Female Rats
Marina Gabaglio, Erica Zamberletti, Manenti Cristina, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8899-8899
Open Access | Times Cited: 22
Palmitoylethanolamide and Its Biobehavioral Correlates in Autism Spectrum Disorder: A Systematic Review of Human and Animal Evidence
Marco Colizzi, Riccardo Bortoletto, Rosalia Costa, et al.
Nutrients (2021) Vol. 13, Iss. 4, pp. 1346-1346
Open Access | Times Cited: 19
Is It Time to Test the Antiseizure Potential of Palmitoylethanolamide in Human Studies? A Systematic Review of Preclinical Evidence
Riccardo Bortoletto, Matteo Balestrieri, Sagnik Bhattacharyya, et al.
Brain Sciences (2022) Vol. 12, Iss. 1, pp. 101-101
Open Access | Times Cited: 13
Elucidation of partial activation of cannabinoid receptor type 2 and identification of potential partial agonists: Molecular dynamics simulation and structure-based virtual screening
Abdullahi İbrahim Uba, Harika Aluwala, Haiguang Liu, et al.
Computational Biology and Chemistry (2022) Vol. 99, pp. 107723-107723
Open Access | Times Cited: 12
The Autism–Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System
Marco Colizzi, Riccardo Bortoletto, Rosalia Costa, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 9, pp. 5616-5616
Open Access | Times Cited: 11
Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen
Kennadi Johnson, Abby J. Weldon, Melissa A. Burmeister
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
A Mini-Review of Relationships Between Cannabis Use and Neural Foundations of Reward Processing, Inhibitory Control and Working Memory
Kristen P. Morie, Marc N. Potenza
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 14
A pilot safety, tolerability and pharmacokinetic study of an oro-buccal administered cannabidiol-dominant anti-inflammatory formulation in healthy individuals: a randomized placebo-controlled single-blinded study
Luis Vitetta, Belinda Butcher, Jeremy D. Henson, et al.
Inflammopharmacology (2021) Vol. 29, Iss. 5, pp. 1361-1370
Closed Access | Times Cited: 13
Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts
Alberto Sainz-Cort, Daniel Jiménez‐Garrido, Elena Muñoz Marrón, et al.
Journal of Clinical Psychopharmacology (2021) Vol. 41, Iss. 5, pp. 561-570
Closed Access | Times Cited: 12
Significados do uso de maconha por pessoas com diagnóstico de esquizofrenia
Lívia Sicaroni Rufato, Clarissa Mendonça Corradi-Webster
Revista Psicologia em Pesquisa (2024) Vol. 18, Iss. 2
Open Access | Times Cited: 1
Interactions between metabotropic glutamate and CB1 receptors: implications for mood, cognition, and synaptic signaling based on data from mGluR and CB1R-targeting drugs
Katarzyna Stachowicz
Pharmacological Reports (2024) Vol. 76, Iss. 6, pp. 1286-1296
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top